Please login to the form below

Not currently logged in
Email:
Password:

Pegasus joins Ashfield Healthcare Communications

Acquired by UDG Healthcare in “strategically important” £16.8m deal
Pegasus joins Ashfield Healthcare Communications

From left: Simon Hackett, Lisa Bradley, Viv Adshead and David Moore

UK healthcare consultancy Pegasus has been bought by UDG Healthcare in a deal valued at up to £16.8m.

Pegasus becomes part of Ashfield Healthcare Communications, a subsidiary of UDG Healthcare's Ashfield Commercial and Medical Services Division, and will be under the leadership of its director David Moore.

Moore said that the acquisition of the healthcare consultancy is “strategically important” for the outsourced services provider.

“It strengthens our existing communications offering and broadens our capabilities in patient and consumer communications programmes, as well as corporate reputation and crisis management for our growing client base,” he added.

Pegasus is one of the UK's largest consumer healthcare-focused PR firms, with a team of 100 employees based in Brighton. Current clients include Daiichi Sankyo, Denplan, DuPont, Lloyds Pharmacy and Novo Nordisk.

Deputy managing director Simon Hackett becomes managing director, while Pegasus' founder Lisa Bradley will become the agency's chairman, taking over from Tim Adams who is departing.

Bradley commented: “Joining Ashfield will increase the breadth and depth of services we offer to our clients and will provide staff with the opportunity to acquire new skills.

“We know they are the right cultural fit for our agency and they share our passion for delivering innovative campaigns across healthcare.”

Article by
Rebecca Clifford

24th May 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...